Evgen Pharma to focus on more profitable partnerships as JuvLife tie-up ends
Evgen Pharma PLC (AIM:EVG), the clinical-stage drug development company, has announced the termination of its patent and know-how licence agreement with...
Source: proactiveinvestors.co.uk